Replies to post #348698 on Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

When the time is right, Nasrat is ready to Rock & Roll.

Drug C below

Elite's Unique second generation IR ADF is 90% cheaper to produce compared to ADFs containing Naltrexone. It can also be used with CNS stimulants to make them abuse deterrent.
The holy grail of IR ADFs trials resume in 2020
Making others obsolete.

Hammer locking the IR ADF market in 2021

Patent Pending

Quote Nasrat:

“I am extremely excited about this formulation because it is also a platform that applies to all the IRs and its about 10% of the cost. So we're extremely excited about this, but it's still early, in the next few months once Dr. Smith files a patent and we do a few more trials, we’ll update everyone more about it. “




Accumulators out in full force



ELTP

[dr_lowenstein]

a PR from almost three years ago, weak proof that they actually could formulate the product